FDA Releases Draft Guidance on Antibacterial Drug Development

Article Read time:
Projects: Antibiotic Resistance
FDA Releases Draft Guidance on Antibacterial Drug Development

Nearly a year after the enactment of the Generating Antibiotic Incentives Now Act, the U.S. Food and Drug Administration has released draft guidance for industry on developing antibacterial therapies for patients with unmet medical needs.

You can find that guidance at: http://www.fda.gov/downloads/Drugs/GuidanceCompliance.

RELATED
Projects
Antibiotic Resistance

ADDITIONAL RESOURCES

Article

July 15, 2024 WHO Warns That Antibiotic Innovation Still Insufficient

Article

May 15, 2024 The Value of Antibiotics Cannot Be Overestimated

Fact Sheet

May 6, 2024 New Measures Curbing Inappropriate Use of Antibiotics

MORE FROM PEW

Thick green marsh grasses line some of the banks of a sprawling bay under a sky half obscured by a bank of clouds. Plan Could Help North Florida Estuary, Famous Oyster Bay
What the Pandemic-Era Revenue Wave Means for State Budgets
Reforms Spur Faster Housing Approvals in California
Why Cancer Resists Treatment Why Cancer Resists Treatment
Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.
Quick View
Pills illustration

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.